IDiyas

For the Inventor, By the Inventor

Scotch Plains, NJ, United States of America

Susan M Schmitt

USPTO Granted Patents = 22 

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 143(Granted Patents)


Location History:

  • South Plains, NJ (US) (1992)
  • Scotch Plains, NJ (US) (1980 - 1994)
  • Los Altos Hills, CA (US) (2010)

Company Filing History:

goldMedal21 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1980-2010

Loading Chart...
22 patents (USPTO):
1. 7661157 - Portable crib or containment device (2010-02-16),
2. 5342933 - Cationic-2-heteroarylphenyl-carbapenem antibacterial agents (1994-08-30),
3. 5292879 - Intermediates for preparing cationic-2-heteroaryl-phenyl-carbapenem (1994-03-08),
4. 5220011 - Intermediates for preparing 2-heteroarylphenyl-carbapenem antibacterial (1993-06-15),
5. 5208229 - 2-(1,2,3-triazolylsubstituted)phenyl carbapenem antibacterial agents (1993-05-04),
6. 5143914 - 2-heteroarylphenyl-carbapenem antibacterial agents (1992-09-01),
7. 5128335 - 2-heteroarylphenyl-carbapenem antibacterial agents (1992-07-07),
8. 4997936 - 2-carbamimidoyl-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids (1991-03-05),
9. 4992542 - 2-substituted-6-carbadethiapen-2-em-3-carboxylic acids (1991-02-12),
10. 4873324 - Process for chiral synthesis of 1-beta-methyl-carbapenem intermediates (1989-10-10),
11. 4734497 - Intermediates for process for chiral synthesis of (1988-03-29),
12. 4617152 - .beta.-lactams containing an .alpha.-exocyclic double bond (1986-10-14),
13. 4595750 - Process for chiral synthesis of 1-.beta.-methylcarbapenem intermediates (1986-06-17),
14. 4347368 - 3 (1982-08-31),
15. 4347367 - 3-Substituted-6-(1'-hydroxyethyl)-7-oxo-1-azabicyc (1982-08-31),

Title: The Innovative Contributions of Susan M. Schmitt

Introduction: Susan M. Schmitt, based in Scotch Plains, NJ, has established herself as a leading inventress in the field of antibacterial agents. With an impressive portfolio of 21 patents, she has made significant strides in medical innovations, particularly through her work in pharmaceutical research and development.

Latest Patents: Among her notable inventions are her latest patents focusing on cationic-2-heteroarylphenyl-carbapenem antibacterial agents. These carbapenems demonstrate potential as effective antibacterial agents, addressing the growing concern of antibiotic resistance. In addition, her work includes developing intermediates for preparing cationic-2-heteroaryl-phenyl-carbapenem compounds, a critical step in producing novel antibacterial agents.

Career Highlights: Susan has built her career at Merck & Company, Inc., a leader in the pharmaceutical industry. Throughout her tenure, she has contributed to numerous research projects that have advanced the development of innovative treatments. Her dedication to improving healthcare outcomes through effective compounds has placed her at the forefront of pharmaceutical innovation.

Collaborations: Working alongside esteemed colleagues like Burton G. Christensen and David B. Johnston, Susan has fostered a collaborative environment that encourages creativity and scientific exploration. These partnerships have been instrumental in driving forward the research initiatives within her domain.

Conclusion: Susan M. Schmitt’s contributions to the field of antibacterial agents highlight her innovative spirit and commitment to addressing crucial healthcare challenges. With her extensive patent portfolio and collaborative efforts at Merck & Company, Inc., she continues to pave the way for future advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…